May 2026
1. GREWAL US, Patel RR, Loeffler BT, Rathjens S, et al
   Germline genetic testing among patients with pancreatic adenocarcinoma: A Pancreatic Cancer Action Network patient survey.
   Cancer. 2026;132:e70446.
   

   >> Share

   
   February 2026
2. MONTGOMERY B, Lynch JA, Brown J, Maxwell KN, et al
   Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program pilot study.
   Cancer. 2026;132:e70283.
   

   >> Share

   
   July 2025
3. KIM Y, Doma V, Cakir U, Kuras M, et al
   Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies.
   Cancer. 2025;131:e35897.
   

   >> Share

   
   March 2025
4. PATEL RB, Sheng T, Diniz MA, Sparano JA, et al
   Impact of race/ethnicity on MammaPrint genomic assay risk and prognosis in early breast cancer: A National Cancer Data Base analysis.
   Cancer. 2025;131:e35771.
   

   >> Share

   
   February 2025
5. NERO C, Trozzi R, Persiani F, Rossi S, et al
   POLE mutations in endometrial carcinoma: Clinical and genomic landscape from a large prospective single-center cohort.
   Cancer. 2025;131:e35731.
   

   >> Share

   
   December 2024
6. MUKAND NH, Chirikova E, Lichtensztajn D, Negoita S, et al
   Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake.
   Cancer. 2024;130:4298-4305.
   

   >> Share

   
   November 2024
7. BROWN K, Ponton M, Davidson E, Arun B, et al
   What do cancer genetic providers want us to know about variant reclassification and recontact that we are not asking? A thematic analysis of open-ended survey responses.
   Cancer. 2024;130:3926-3934.
   

   >> Share

   
   August 2024
8. WU Q, Hu C, Feng L, Yang X, et al
   Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma.
   Cancer. 2024 Aug 14. doi: 10.1002/cncr.35517.
   

   >> Share

   
   July 2024
9. MARTINI DJ, Case KB, Gratz D, Pellegrini K, et al
   PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation.
   Cancer. 2024 Jul 3. doi: 10.1002/cncr.35465.
   

   >> Share

   
   May 2024
10. HSIEH AL, Bi WL, Ramesh V, Brastianos PK, et al
    Evolving concepts in meningioma management in the era of genomics.
    Cancer. 2024 May 16. doi: 10.1002/cncr.35279.
    

    >> Share

    
    
11. NIERENGARTEN MB
    First person profile: Barbara Burtness, MD: For more than 20 years, she has applied advances in molecular biology to better treat patients with head and neck cancers.
    Cancer. 2024;130:1724.
    

    >> Share

    
    March 2024
12. KOTECHA RR, Knezevic A, Arora K, Bandlamudi C, et al
    Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
    Cancer. 2024;130:692-701.
    

    >> Share

    
    February 2024
13. YEKU OO
    Racial disparities and referral for genetic counseling.
    Cancer. 2024;130:505-506.
    

    >> Share

    
    
14. NGUYEN SM, Tran HTT, Long J, Shrubsole MJ, et al
    Gut microbiome in association with chemotherapy-induced toxicities among patients with breast cancer.
    Cancer. 2024 Feb 6. doi: 10.1002/cncr.35229.
    

    >> Share

    
    January 2024
15. BRAUN AE, Chan JM, Neuhaus J, Cowan JE, et al
    The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer.
    Cancer. 2024 Jan 27. doi: 10.1002/cncr.35215.
    

    >> Share

    
    November 2023
16. HOWARD SHARP KM, Nichols KE
    Insights into parent and adolescent patient understanding of genomic sequencing.
    Cancer. 2023;129:3519-3521.
    

    >> Share

    
    October 2023
17. NIERENGARTEN MB
    Genomics likely are not the main driver in advanced prostate cancer overall survival rate disparities.
    Cancer. 2023;129:3192.
    

    >> Share

    
    September 2023
18. DASH C, Mills MG, Jones TD, Nwabukwu IA, et al
    Design and pilot implementation of the Achieving Cancer Equity through Identification, Testing, and Screening (ACE-ITS) program in an urban underresourced population.
    Cancer. 2023;129.
    

    >> Share

    
    June 2023
19. MOORADIAN MJ, Cleary JM, Giobbie-Hurder A, Darville LNF, et al
    Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors.
    Cancer. 2023;129:1904-1918.
    

    >> Share

    
    April 2023
20. NIERENGARTEN MB
    Helping oncologists utilize genomics in cancer care: An updated definition of the uses of genetic biomarkers in cancer diagnosis and care can make a difference in how physicians understand their use in the clinic.: An updated definition of the uses of
    Cancer. 2023;129:1140-1141.
    

    >> Share

    
    March 2023
21. OHYAMA H, Hirotsu Y, Amemiya K, Miura Y, et al
    Comparison of genomic profiling of circulating tumor DNA in pancreaticobiliary malignancies in plasma and bile.
    Cancer. 2023 Mar 18. doi: 10.1002/cncr.34717.
    

    >> Share

    
    February 2023
22. GUPTA DG, Varma N, Kumar A, Naseem S, et al
    Genomic and proteomic characterization of Philadelphia-like B-lineage acute lymphoblastic leukemia: A report of Indian patients.
    Cancer. 2023 Feb 3. doi: 10.1002/cncr.34665.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share